- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05120843
Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth
January 23, 2026 updated by: Children's Hospital of Philadelphia
Feasibility Testing of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth
This study continues an adaptation of care coordination to address the needs of women after preterm birth.
This is a small single arm open trial designed to test intervention implementation and refine the intervention before ongoing feasibility testing.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Interventionists will be trained in care coordination strategies and Motivational Interviewing (MI) techniques.
Following training, investigators will enroll eligible women from a postpartum unit at a single hospital, or within two weeks of birth.
Investigators will assess feasibility, adoption, reach, and fidelity of the intervention and of study data collections strategies.
The intervention protocol will be revised to reflect these assessments.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 45 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Female
- Less than 45 years old
- History of preterm birth (< 34 weeks gestational age or 34 - 36 weeks with identifiable risk factors for recurrent preterm birth which may include low preventive care utilization, tobacco use, obesity, depression or anxiety, or history of unmet contraceptive needs)
- Intention to seek pediatric care at one of two pediatric primary care sites
- Medicaid insurance
Exclusion Criteria:
- History of sterilization procedure.
- Plan to move away from the area or transfer pediatric primary care within six months of enrollment.
- Limited English proficiency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Intervention Arm
This intervention will combine care coordination and motivational interviewing strategies.
|
Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing.
The final intervention is expected to be six months in duration.
However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Screening Rate (Feasibility)
Time Frame: Screening phase (Up to 1 week prior to enrollment)
|
The study team will compare the number of potentially eligible participants to those who are screened for eligibility.
The number screened will be defined as the number of people whose are reviewed to approach for enrollment.
The number of potentially eligible participants will be considered the number of women with preterm births with Medicaid insurance.
|
Screening phase (Up to 1 week prior to enrollment)
|
|
Enrollment Rate (Feasibility)
Time Frame: Screening phase (Up to one week prior to enrollment)
|
The study team will track the proportion of eligible women approached for enrollment who enroll in the study.
|
Screening phase (Up to one week prior to enrollment)
|
|
Reasons for Non-participation (Acceptability)
Time Frame: Screening phase (Up to 1 week prior to enrollment)
|
For women who decline enrollment we will ask them, if they are willing, to provide reasons for non-participation and potential study modifications that might have encouraged them to participate.
Responses will be tabulated and reviewed for potential themes.
|
Screening phase (Up to 1 week prior to enrollment)
|
|
Retention Rate (Feasibility)
Time Frame: Enrollment through six months
|
The study team will track the proportion of enrolled participants who complete the intervention and the study assessments.
|
Enrollment through six months
|
|
Number of Completed Assessments (Feasibility)
Time Frame: Enrollment through six months
|
The study team will track the proportion of the baseline, 3-month, and 6-month assessments that are completed.
|
Enrollment through six months
|
|
Care Coordination Fidelity (Feasibility)
Time Frame: Enrollment through six months
|
We will assess the proportion of intervention components completed, including interventionist completion of screening tools, as well as other tasks outlined in the care plan, including focused education, navigation, and addressing barriers to care, screening.
|
Enrollment through six months
|
|
Motivational Interviewing (MI) Fidelity (Feasibility)
Time Frame: Enrollment through six months
|
OnePass is a validated tool used to evaluate MI practice and assess fidelity based on review of a single session, using 23 items to assess MI components.61
This tool yields a global score while also identifying specific areas for additional practice and training.
Scores range from 1 - 7 with 5 considered a minimum for competence.
Interventionists will complete at least one OnePass within a month of starting MI sessions with participants.
|
Enrollment through six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Autonomy Support
Time Frame: Baseline and 3 months
|
Autonomy support will be measured with the short form of the Health Care Climate Questionnaire (6 items, range 6 - 42, Cronbach alpha 0.82).
Scores on the short form 6-item version are calculated by averaging the individual item scores.
Higher average scores represent a higher level of perceived autonomy support.
|
Baseline and 3 months
|
|
Change in Autonomous Motivation
Time Frame: Baseline and 6 months
|
Autonomous motivation will be measured using the Autonomous Motivation and External Regulation scales of the Treatment Self-Regulation Questionnaire (10 items, range 7 - 70, Cronbach alpha 0.90) with a higher score indicating higher emotion regulation strategy.
|
Baseline and 6 months
|
|
Count of Preventive Care Visits
Time Frame: 6 months
|
This will include postpartum visits, visits for contraceptive management, routine preventive care visits, and visits to follow-up on complications of pregnancy (secondary prevention).
Visits will be abstracted from the health record and from interventionist records.
|
6 months
|
|
Proportion of Recommended Care Completed
Time Frame: 6 months
|
This Outcome Measure reports the average percentage of the recommended care plan completed among participants.
Recommended care will be abstracted from a care plan completed within the first two weeks after enrollment.
Completed care will be abstracted from the health record and from interventionist records.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 3, 2022
Primary Completion (Actual)
September 23, 2023
Study Completion (Actual)
September 23, 2023
Study Registration Dates
First Submitted
September 13, 2021
First Submitted That Met QC Criteria
November 12, 2021
First Posted (Actual)
November 15, 2021
Study Record Updates
Last Update Posted (Actual)
January 27, 2026
Last Update Submitted That Met QC Criteria
January 23, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Body Weight
- Obstetric Labor, Premature
- Obstetric Labor Complications
- Pregnancy Complications
- Behavioral Symptoms
- Pathological Conditions, Signs and Symptoms
- Behavior
- Signs and Symptoms
- Treatment Adherence and Compliance
- Health Behavior
- Reproductive Behavior
- Premature Birth
- Birth Weight
- Depression
- Tobacco Use
- Patient Acceptance of Health Care
- Contraception Behavior
- Health Services
- Health Care Facilities Workforce and Services
- Behavioral Disciplines and Activities
- Directive Counseling
- Counseling
- Mental Health Services
- Motivational Interviewing
Other Study ID Numbers
- 20-017871
- 1K23HD102560 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data will be used to refine the protocol for further testing.
There are no plans to share individual participant data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Care coordination and motivational interviewing
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); University of Iowa; American... and other collaboratorsCompletedChildhood ObesityUnited States
-
Hopital du Sacre-Coeur de MontrealCompleted
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Food and Health Bureau, Hong KongUnited Christian Hospital; Haven of Hope HospitalCompletedEnd Stage DiseaseHong Kong
-
VA Office of Research and DevelopmentCompleted
-
Nationwide Children's HospitalNational Institute on Drug Abuse (NIDA)CompletedDepression | Risk Behavior | Suicidal Ideation | Substance UseUnited States
-
Yale UniversityPatient-Centered Outcomes Research InstituteCompletedSexual AbuseUnited States
-
The University of Texas Health Science Center,...HRSA/Maternal and Child Health BureauCompletedInfant Environmental Tobacco Smoke ExposureUnited States
-
Wroclaw Medical UniversityUniversity of Rome Tor VergataNot yet recruitingSelf Care | Caregiver | Heart Failure (HF) | Motivational Interviewing (MI)Poland